Safety and immunogenicity of investigational tuberculosis vaccine M72/AS01E-4 in people living with HIV in South Africa: an observer-blinded, randomised, controlled, phase 2 trial. - Dagnew AF; Han LL; Naidoo K; Fairlie L; Innes JC; Middelkoop K; Tameris M; Wilkinson RJ; Ananworanich J; Bower D; Schlehuber L; Frahm N; et al. (The lancet. HIV, 2025)